Glipizide and Gallbladder cholesterolosis - a phase IV clinical study of FDA data

Summary:

Gallbladder cholesterolosis is reported only by a few people who take Glipizide.

The phase IV clinical study analyzes which people take Glipizide and have Gallbladder cholesterolosis. It is created by eHealthMe based on reports of 59,145 people who have side effects while taking Glipizide from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 07, 2023

59,145 people reported to have side effects when taking Glipizide.
Among them, 5 people (0.01%) have Gallbladder cholesterolosis.

What is Glipizide?

Glipizide has active ingredients of glipizide. It is often used in diabetes. eHealthMe is studying from 60,263 Glipizide users for its effectiveness, alternative drugs and more.

What is Gallbladder cholesterolosis?

Gallbladder cholesterolosis (accumulation and deposition of cholesterol inside of the) is found to be associated with 661 drugs and 378 conditions by eHealthMe.

Number of Glipizide and Gallbladder cholesterolosis reports submitted per year:

Could Glipizide cause Gallbladder cholesterolosis?

Gender of people who have Gallbladder cholesterolosis when taking Glipizide *:

female: 80 %
male: 20 %

Age of people who have Gallbladder cholesterolosis when taking Glipizide *:

Common drugs people take besides Glipizide *:

Common side effects people have besides Gallbladder cholesterolosis *:

Nausea And Vomiting: 5 people, 100.00%
Abdominal Pain: 5 people, 100.00%
Nausea (feeling of having an urge to vomit): 5 people, 100.00%
Urinary Tract Infection: 4 people, 80.00%
Abdominal Pain Upper: 4 people, 80.00%
Biliary Dyskinesia (motility disorder that affects the gallbladder and sphincter of oddi): 4 people, 80.00%
Fever: 3 people, 60.00%
Gastric Disorder (disease of stomach): 3 people, 60.00%
Cholecystitis (infection of gallbladder): 3 people, 60.00%
Chills (felling of cold): 3 people, 60.00%

Common conditions people have *:

Asthma: 3 people, 60.00%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 60.00%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 3 people, 60.00%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 3 people, 60.00%
Uterine Haemorrhage (uterine bleeding): 3 people, 60.00%
Polycystic Ovary Disease (cysts in the ovaries that occurs when the follicle stops developing): 2 people, 40.00%
Vaginal Infection: 1 person, 20.00%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 20.00%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 20.00%
Blood Iron Decreased: 1 person, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Glipizide and have Gallbladder cholesterolosis?

Check whether Gallbladder cholesterolosis is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Das S, Anand Ramasamy SD, Mondal S, "An unusual case of glipizide-induced proximal myopathy", Journal of pharmacology & pharmacotherapeutics, 2016 Jan .

Related studies

How severe was Gallbladder cholesterolosis and when was it recovered:

Gallbladder cholesterolosis in Glipizide

Expand to all the drugs that have ingredients of glipizide:

Gallbladder cholesterolosis and drugs with ingredients of glipizide

Alternative drugs to, pros and cons of Glipizide:

Glipizide (60,263 reports)

Common Glipizide side effects:

Fatigue (feeling of tiredness): 3,456 reports
Drug ineffective: 3,396 reports
Diarrhea: 3,178 reports
Weakness: 2,858 reports
Breathing difficulty: 2,846 reports
Weight decreased: 2,690 reports

Browse all side effects of Glipizide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Gallbladder cholesterolosis treatments and more:

Gallbladder cholesterolosis (994 reports)

COVID vaccines that are related to Gallbladder cholesterolosis:

Common drugs associated with Gallbladder cholesterolosis:

Yasmin: 596 reports
Yaz: 493 reports
Drospirenone and ethinyl estradiol: 115 reports
Ibuprofen: 106 reports
Ibu: 106 reports
Profen: 106 reports

All the drugs that are associated with Gallbladder cholesterolosis:

Gallbladder cholesterolosis (661 drugs)

Common conditions associated with Gallbladder cholesterolosis:

Birth control: 341 reports
Premenstrual syndrome: 155 reports
Acne: 123 reports

All the conditions that are associated with Gallbladder cholesterolosis:

Gallbladder cholesterolosis (378 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on glipizide (the active ingredients of Glipizide) and Glipizide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.